Universe Pharmaceuticals (UPC) Finished Goods (2021 - 2025)

Universe Pharmaceuticals (UPC) has 5 years of Finished Goods data on file, last reported at $1.6 billion in Q3 2025.

• For the quarter ending Q3 2025, Finished Goods rose 40.91% year-over-year to $1.6 billion; the trailing twelve-month figure through Sep 2025 stood at $1.6 billion (up 40.91% YoY), and the FY2025 full-year result was $1.6 billion, up 40.91% from the prior year.
• Finished Goods grew to $1.6 billion in Q3 2025, from $1.1 billion in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $1.6 billion in Q3 2025 to a low of $1.3 million in Q3 2022.
• A 5-year average of $551.2 million and a median of $2.8 million in 2023 frame the typical range for Finished Goods.
• Across the five-year window, Finished Goods sank 32.14% in 2022 and soared 40997.28% in 2024, its largest moves.
• Tracing UPC's Finished Goods over 5 years: stood at $2.0 million in 2021, then plunged by 32.14% to $1.3 million in 2022, then surged by 107.64% to $2.8 million in 2023, then soared by 40997.28% to $1.1 billion in 2024, then soared by 40.91% to $1.6 billion in 2025.
• Business Quant data shows UPC's Finished Goods at $1.6 billion in Q3 2025, $1.1 billion in Q3 2024, and $2.8 million in Q3 2023.